The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Single institution experience of chemoradiation with gemcitabine versus capecitabine in borderline resectable and locally advanced pancreatic cancer.
Adam S. Kotowski
No relevant relationships to disclose
Naveen Yarlagadda
No relevant relationships to disclose
Kilian Salerno May
No relevant relationships to disclose
Graham Walter Warren
No relevant relationships to disclose
Boris W. Kuvshinoff
No relevant relationships to disclose
Neal W. Wilkinson
No relevant relationships to disclose
Wei Tan
No relevant relationships to disclose
Renuka V. Iyer
No relevant relationships to disclose
Wen Wee Ma
No relevant relationships to disclose